We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
(-3.5%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$72.5M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$54.4M |
| 3 |
Blackstone
BX
|
+$44M |
| 4 |
Airbnb
ABNB
|
+$37.4M |
| 5 |
Everest Group
EG
|
+$30.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$57.8M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$39.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
| 4 |
iShares Global Infrastructure ETF
IGF
|
+$19.2M |
| 5 |
PDCE
PDC Energy, Inc.
PDCE
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.73% |
| 2 | Healthcare | 12.76% |
| 3 | Financials | 12.67% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Teva Pharmaceuticals
TEVA
$41.2B
| $3.05M | ﹤0.01% |
299,000
+33,436
| +13% | +$311K |
|
1627
Arcus Biosciences
RCUS
$3.64B
| $3.05M | ﹤0.01% |
169,849
+4,063
| +2% | +$81.6K |
|
1628
Leslie's
LESL
$11M
| $3.05M | ﹤0.01% |
26,913
+2,262
| +9% | +$296K |
|
|
CSR
1629
Centerspace
CSR
$952M
| $3.04M | ﹤0.01% |
50,409
-575
| -1% | -$35.9K |
|
|
STEL
1630
DELISTED
Stellar Bancorp
STEL
| $3.04M | ﹤0.01% |
142,400
+1,898
| +1% | +$43.3K |
|
1631
AtriCure
ATRC
$2.11B
| $3.03M | ﹤0.01% |
69,181
-2,912
| -4% | -$142K |
|
|
VBTX
1632
DELISTED
Veritex Holdings
VBTX
| $3.02M | ﹤0.01% |
168,108
-154
| -0.1% | -$2.97K |
|
1633
Prothena Corp
PRTA
$450M
| $3.01M | ﹤0.01% |
62,451
+1,661
| +3% | +$98.7K |
|
|
CHS
1634
DELISTED
Chicos FAS, Inc.
CHS
| $3M | ﹤0.01% |
401,714
-5,274
| -1% | -$28.3K |
|
1635
Corebridge Financial
CRBG
$15B
| $3M | ﹤0.01% |
152,119
+63,903
| +72% | +$1.19M |
|
1636
Monro
MNRO
$398M
| $3M | ﹤0.01% |
108,062
+57
| +0.1% | +$1.97K |
|
1637
Trupanion
TRUP
$1.18B
| $3M | ﹤0.01% |
106,393
+152
| +0.1% | +$4.32K |
|
1638
Nelnet
NNI
$4.7B
| $2.99M | ﹤0.01% |
33,450
+1,144
| +4% | +$108K |
|
1639
SSR Mining
SSRM
$6.48B
| $2.99M | ﹤0.01% |
224,728
-7,400
| -3% | -$107K |
|
|
DOOR
1640
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $2.98M | ﹤0.01% |
32,012
-778
| -2% | -$78.2K |
|
1641
Harmonic Inc
HLIT
$1.28B
| $2.98M | ﹤0.01% |
309,421
-1,499
| -0.5% | -$17.9K |
|
1642
RLJ Lodging Trust
RLJ
$1.69B
| $2.98M | ﹤0.01% |
303,968
-2,182
| -0.7% | -$21.8K |
|
|
VTLE
1643
DELISTED
Vital Energy
VTLE
| $2.97M | ﹤0.01% |
53,642
-2,524
| -4% | -$136K |
|
1644
Ambarella
AMBA
$3.81B
| $2.97M | ﹤0.01% |
56,012
+2,540
| +5% | +$178K |
|
1645
A10 Networks
ATEN
$1.95B
| $2.96M | ﹤0.01% |
197,056
-15,995
| -8% | -$237K |
|
1646
Hain Celestial
HAIN
$53.7M
| $2.95M | ﹤0.01% |
284,850
-1,480
| -0.5% | -$17.1K |
|
1647
Simulations Plus
SLP
$371M
| $2.95M | ﹤0.01% |
70,796
-15,898
| -18% | -$721K |
|
1648
Upstart Holdings
UPST
$3.03B
| $2.94M | ﹤0.01% |
103,151
+1,860
| +2% | +$74.8K |
|
|
STR
1649
DELISTED
Sitio Royalties
STR
| $2.94M | ﹤0.01% |
121,296
+2,792
| +2% | +$71.9K |
|
1650
Ginkgo Bioworks
DNA
$521M
| $2.94M | ﹤0.01% |
40,558
-84
| -0.2% | -$6.72K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
- RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
- RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
- RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
- RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.
Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.